SUBSCRIBE
SUBSCRIBE

Newsfile Corp

IN THE PRESS
Marvel Biosciences Successfully Completes Maximum Tolerated Dose Study, a Critical Milestone Towards FDA Clinical Studies
October 17, 2022
 · 
4 min read
FDA
Pacylex Announces Orphan Drug Designation Granted to PCLX-001 for the Treatment of Acute Myeloid Leukemia
October 14, 2022
 · 
2 min read
NovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding, Provides Financial Update
October 13, 2022
 · 
5 min read
Kiora Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
October 13, 2022
 · 
3 min read
BioHarvest Sciences Inc. Announces Closing of the First Tranche of Private Placement of Convertible Notes
October 13, 2022
 · 
4 min read
Defence Therapeutics Initiates Lung Cancer Treatment Program with Its Novel AccuTOX(TM) Formulation via Intranasal
October 12, 2022
 · 
4 min read
NervGen Pharma Awarded up to $1.5 Million US Department of Defense Funding to Evaluate NervGen’s NVG-291-R for Peripheral Nerve Injury
October 12, 2022
 · 
10 min read
Major Grant Awarded to Study PCLX-001 in Acute Myeloid Leukemia Patients
October 11, 2022
 · 
2 min read
Drug Development
Satellos Bioscience Inc. to Present Preliminary Preclinical Proof of Concept Data for an Additional Rare Disease at World Muscle Society Meeting
October 11, 2022
 · 
5 min read
MustGrow Receives Conditional Approval to Up-List to the TSX Venture Exchange
October 11, 2022
 · 
4 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us